Stock listing
OTC:ELTP Elite Pharmaceuticals, Inc. Stock
Follow Elite Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · OTC:ELTP
$0.322 USD -0.036 (-10.1%)
Close on Nov 20, 2026
- Day range
- $0.315 – $0.336 USDNov 20, 2026
- Volume
- 155,111 sharesNov 20, 2026
- Market cap
- $347.2M USDAt the close on Nov 20, 2026 · price × 1.08B shares outstanding
- 52-week range
- $0.210 – $0.550 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $210,655 USDMedian day 595,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:ELTP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.322 | -0.036 | -10.1% | $0.316 | $0.336 | $0.315 | 155,111 | |
| $0.359 | -0.010 | -2.8% | $0.375 | $0.375 | $0.340 | 343,562 | |
| $0.369 | -0.001 | -0.3% | $0.373 | $0.392 | $0.358 | 568,878 | |
| $0.370 | +0.050 | +15.6% | $0.335 | $0.375 | $0.325 | 1,085,586 | |
| $0.320 | +0.070 | +28.0% | $0.250 | $0.350 | $0.250 | 4,629,500 | |
| $0.250 | +0.010 | +4.2% | $0.220 | $0.250 | $0.220 | 225,800 | |
| $0.240 | 0.000 | 0.0% | $0.210 | $0.250 | $0.210 | 866,100 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.230 | 383,900 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 241,200 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 488,200 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.220 | 700,300 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.220 | 396,100 | |
| $0.240 | +0.020 | +9.1% | $0.230 | $0.250 | $0.220 | 809,700 | |
| $0.220 | -0.010 | -4.3% | $0.230 | $0.230 | $0.220 | 326,100 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.220 | 796,100 | |
| $0.230 | -0.010 | -4.2% | $0.250 | $0.250 | $0.230 | 1,528,100 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 199,700 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 206,000 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.230 | 1,229,800 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.230 | 297,000 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 258,900 | |
| $0.250 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 223,400 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.240 | 742,300 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.240 | 488,700 | |
| $0.250 | 0.000 | 0.0% | $0.260 | $0.260 | $0.240 | 509,600 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.220 | 710,400 | |
| $0.250 | -0.010 | -3.8% | $0.250 | $0.260 | $0.240 | 481,300 | |
| $0.260 | 0.000 | 0.0% | $0.250 | $0.260 | $0.250 | 353,400 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.250 | 384,900 | |
| $0.260 | -0.010 | -3.7% | $0.260 | $0.270 | $0.250 | 638,500 | |
| $0.270 | +0.020 | +8.0% | $0.250 | $0.270 | $0.250 | 829,100 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.240 | 580,700 | |
| $0.250 | +0.030 | +13.6% | $0.230 | $0.250 | $0.220 | 1,660,000 | |
| $0.220 | -0.010 | -4.3% | $0.220 | $0.230 | $0.210 | 1,657,800 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.240 | $0.220 | 1,868,100 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.240 | $0.230 | 1,153,800 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 659,000 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.230 | 1,467,300 | |
| $0.250 | -0.010 | -3.8% | $0.260 | $0.260 | $0.240 | 641,200 | |
| $0.260 | +0.010 | +4.0% | $0.250 | $0.260 | $0.250 | 509,500 | |
| $0.250 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 290,700 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 278,000 | |
| $0.250 | +0.010 | +4.2% | $0.240 | $0.250 | $0.240 | 408,700 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 327,100 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 462,200 | |
| $0.250 | +0.010 | +4.2% | $0.250 | $0.250 | $0.240 | 595,000 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.250 | $0.240 | 874,900 | |
| $0.250 | -0.010 | -3.8% | $0.260 | $0.260 | $0.250 | 534,200 | |
| $0.260 | 0.000 | 0.0% | $0.250 | $0.260 | $0.250 | 1,236,900 | |
| $0.260 | +0.010 | +4.0% | $0.260 | $0.270 | $0.250 | 398,000 | |
| $0.250 | -0.010 | -3.8% | $0.260 | $0.270 | $0.250 | 854,500 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.260 | 373,700 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.240 | 685,600 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.250 | 2,027,500 | |
| $0.260 | -0.020 | -7.1% | $0.280 | $0.280 | $0.260 | 1,521,900 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.280 | $0.280 | 342,000 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.290 | $0.280 | 459,500 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 261,400 | |
| $0.290 | 0.000 | 0.0% | $0.300 | $0.300 | $0.290 | 1,930,000 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 1,481,200 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 954,700 | |
| $0.290 | 0.000 | 0.0% | $0.290 | $0.290 | $0.280 | 998,100 | |
| $0.290 | -0.010 | -3.3% | $0.300 | $0.300 | $0.290 | 700,800 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.310 | $0.280 | 900,900 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.310 | $0.290 | 1,322,300 |
- Ticker
- OTC:ELTP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information
Nov 12, 2026
Closed $0.32 (+28.0%) on Nov 13, 2026
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2027 Financial Results on November 13, 2026
Nov 10, 2026
Closed $0.24 (0.0%) on Nov 10, 2026
Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq.
Nov 3, 2026
Closed $0.24 (+9.1%) on Nov 3, 2026
Elite Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 3 in the last 12 months · 3 in all · newest Nov 12, 2026 · oldest 2026
- Decks
- 1 deck · latest November 2005
Valuation
P/E 5.8× against a median of 10.8×: the lowest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $312.3M USD
- P/E
- 5.8×
- EV/sales
- 2.2×
- EV/EBITDA
- 8.3×
- Price/book
- 2.8×
- Gross margin
- 43.7%
- Operating margin
- 25.3%
- Net margin
- 41.6%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.53
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Elite Pharmaceuticals, Inc. · OTC:ELTP | US$347.2M | US$312.3M | 5.8× | 2.2× | 8.3× | 2.8× | 41.6% | 0.0× | 0.53 |
| Wuhan Hiteck Biological Pharma Co., Ltd. Class A · SZSE:300683 | US$368.3M | US$313.1M | n/a | 4.8× | n/a | 1.2× | −44.4% | 0.0× | n/a |
| Blau Farmaceutica SA · BMFBOVESPA:BLAU3 | US$364.0M | US$358.7M | 9.2× | 1.2× | 5.1× | 0.9× | 13.1% | 0.4× | n/a |
| Boiron SA · EURONEXT:BOI | US$359.2M | US$329.7M | 10.0× | 0.6× | 4.5× | 0.9× | 6.5% | 0.1× | n/a |
| Abbott Laboratories Pakistan Limited · PSX:ABOT | US$358.9M | US$321.3M | 10.7× | 1.1× | 5.5× | 2.9× | 11.9% | 0.0× | n/a |
| Unichem Laboratories Limited · NSE:UNICHEMLAB | US$356.3M | US$356.3M | 10.8× | 1.4× | 14.4× | 1.2× | 13.2% | 0.0× | n/a |
| Guizhou Yibai Pharmaceutical Co. Ltd. Class A · SSE:600594 | US$333.3M | US$285.8M | n/a | 1.4× | n/a | 1.1× | −28.0% | 0.0× | n/a |
| Guangdong Lifestrong Pharmacy Co., Ltd. Class A · SZSE:301111 | US$332.8M | US$274.7M | 335× | 6.1× | n/a | 3.0× | 2.2% | 0.0× | n/a |
| Anhui Fengyuan Pharmaceutical Co., Ltd Class A · SZSE:000153 | US$330.6M | US$287.6M | 26.0× | 0.6× | n/a | 1.0× | 2.7% | 0.1× | n/a |
| Tuoxin Pharmaceutical Group Co., Ltd. Class A · SZSE:301089 | US$328.8M | US$300.1M | n/a | 4.7× | n/a | 1.5× | −18.7% | 0.0× | n/a |
| Mayne Pharma Group Ltd. · ASX:MYX | US$327.4M | US$301.5M | 20.2× | 1.2× | 15.5× | 1.3× | 6.4% | 0.1× | n/a |
| Median of the others | US$344.8M | US$307.3M | 10.8× | 1.3× | 5.5× | 1.2× | 4.5% | 0.0× |
Team and board
Officers
| Officer | Role |
|---|---|
| Nasrat Hakim | Chairman, President & Chief Executive Officer |
| Carter Ward | Chief Financial Officer |
| Dianne Will | Investor Relations |
| Doug Plassche | Executive Vice President of Operations |
| G. Kenneth Smith | Vice President of Legal |
| Chris Dick | Head of Development |
| Kirko Kirkov | Chief Commercial Officer |
Board
| Director | Role |
|---|---|
| Nasrat Hakim | Chairman, President & Chief Executive Officer |
| Barry Dash | Director |
| Davis S. Caskey | Director |
| Jeffrey Whitnell | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2027 | Aug 14, 2026 · After close | 0.0% |
| Q2 2026 | Nov 13, 2025 · After close | +1.5% |
| Q1 2026 | Aug 12, 2025 · Before open | 0.0% |
| Q4 2025 | Jun 30, 2025 | −5.6% |
| Q3 2025 | Feb 12, 2025 · After close | 0.0% |
| Q2 2025 | Nov 14, 2024 · After close | +7.7% |
| Q1 2025 | Aug 14, 2024 · After close | −5.0% |
| Q3 2024 | Feb 15, 2024 · After close | +5.6% |
| Q2 2024 | Nov 14, 2023 · After close | +16.7% |
| Q1 2024 | Aug 14, 2023 · After close | +25.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Jun 29, 2023 | 0.0% |
| Q3 2023 | Feb 14, 2023 | 0.0% |
| Q2 2023 | Nov 15, 2022 | −25.0% |
| Q1 2023 | Aug 15, 2022 | 0.0% |
| Q4 2022 | Jun 29, 2022 | +25.0% |
| Q3 2022 | Feb 14, 2022 | 0.0% |
| Quarter to Sep 30, 2021 | Nov 15, 2021 | 0.0% |
| Quarter to Jun 30, 2021 | Aug 16, 2021 | 0.0% |
| Quarter to Mar 31, 2021 | Jun 14, 2021 | −16.7% |
| Quarter to Dec 31, 2020 | Feb 17, 2021 | −25.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2005) | Investor deck | 33 slides | November 2005 |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 148.9M | 84.0M | 56.6M | 34.2M | 32.3M | 25.4M | 18.0M | 7.57M | 7.46M | 9.64M |
| Cost of revenue | 73.8M | 44.0M | 30.3M | 17.6M | 17.5M | 13.5M | 10.0M | 4.70M | 3.51M | 5.90M |
| Gross profit | 75.0M | 40.1M | 26.4M | 16.6M | 14.8M | 11.9M | 7.98M | 2.87M | 3.95M | 3.74M |
| Research and development | 5.74M | 7.96M | 6.88M | 6.20M | 4.05M | 5.11M | 5.53M | 7.60M | 9.62M | 8.30M |
| Operating income | 49.1M | 19.6M | 10.8M | 3.68M | 5.07M | 2.10M | -2.29M | -9.16M | -9.05M | -7.36M |
| Depreciation and amortization | 1.07M | 1.23M | 1.32M | 1.28M | 1.21M | 1.31M | 1.32M | 1.26M | 996.4K | 714.5K |
| EBITDA | 50.2M | 20.8M | 12.1M | 4.95M | 6.28M | 3.42M | -965.6K | -7.90M | -8.05M | -6.64M |
| Interest expense | 111.4K | 128.2K | 588.6K | 1.11M | 191.8K | 259.6K | 355.9K | 369.2K | 335.5K | 238.2K |
| Income before tax | 56.8M | -52.1K | 463.1K | 3.99M | 6.30M | 4.14M | -2.24M | -9.96M | -4.72M | 1.94M |
| Income tax | 11.9M | 4.26M | -19.6M | 424.0K | -1.74M | -676.0K | -1.05M | -1.87M | ||
| Net income | 44.9M | -4.31M | 20.1M | 3.56M | 8.90M | 5.09M | -2.24M | -9.28M | -3.67M | 3.81M |
| Earnings per share, basic | 0.04 | 0.00 | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 | -0.01 | 0.00 | 0.03 |
| Earnings per share, diluted | 0.03 | 0.00 | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 29.8M | 11.3M | 7.11M | 7.83M | 8.54M | 3.19M | 1.13M | 2.28M | 7.18M | 10.6M |
| Receivables | 59.7M | 29.2M | 19.5M | 3.09M | 3.06M | 3.50M | 4.11M | 1.32M | 675.9K | 934.1K |
| Inventory | 21.3M | 16.2M | 12.9M | 9.55M | 6.74M | 5.01M | 4.14M | 4.52M | 4.90M | 6.42M |
| Current assets | 112.1M | 57.7M | 40.0M | 21.5M | 18.9M | 12.2M | 10.3M | 8.86M | 13.7M | 18.4M |
| Property, plant and equipment | 10.2M | 10.3M | 10.2M | 10.4M | 5.95M | 6.65M | 7.23M | 8.44M | 8.99M | 9.04M |
| Total assets | 138.3M | 96.4M | 83.7M | 40.9M | 35.1M | 26.2M | 25.0M | 24.4M | 30.9M | 34.3M |
| Accounts payable | 6.05M | 2.96M | 2.71M | 2.45M | 1.43M | 929.7K | 1.58M | 1.38M | 1.66M | 1.05M |
| Current liabilities | 17.4M | 11.8M | 13.0M | 7.83M | 6.69M | 5.81M | 8.64M | 6.91M | 5.11M | 3.34M |
| Total debt | 1.25M | 1.47M | 1.57M | |||||||
| Total liabilities | 39.4M | 42.9M | 26.1M | 11.9M | 9.93M | 10.0M | 14.3M | 13.0M | 12.4M | 8.65M |
| Shareholders' equity | 98.9M | 53.5M | 57.6M | 29.0M | 25.2M | 16.2M | 10.7M | -2.51M | 4.57M | 25.7M |
| Shares outstanding | 1.08B | 1.07B | 1.07B | 1.01B | 1.01B | 1.01B | 840.4M | 824.8M | 802.5M | 927.9M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 23.7M | 7.46M | -3.24M | 3.34M | 6.51M | 3.19M | -1.79M | -6.79M | -4.81M | -7.88M |
| Capital spending | -925.6K | -1.63M | -809.7K | -5.74M | -498.6K | |||||
| Free cash flow | 22.8M | 5.83M | -4.04M | -2.40M | 6.01M | |||||
| Cash from investing | -925.6K | -2.40M | -809.7K | -5.74M | -498.6K | -262.8K | -35.0K | 330.9K | -274.8K | -1.10M |
| Cash from financing | -4.32M | -825.7K | 3.34M | 1.70M | -667.1K | -869.8K | 689.5K | 1.57M | 1.67M | 8.07M |
| Change in cash | 18.5M | 4.23M | -705.6K | -695.7K | 5.34M | 2.06M | -1.14M | -4.90M | -3.41M | -917.5K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 12, 2026 | Results | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Nov 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 3, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K/A · Current report, amended | Aug 10, 2026 | Current report | SEC |
| 8-K · Current report | Aug 10, 2026 | Current report | SEC |
| 8-K · Current report | Aug 4, 2026 | Current report | SEC |
| 8-K · Current report | Jun 29, 2026 | Results | SEC |
| 10-K · Annual report | Jun 29, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 23, 2026 | Current report | SEC |
| 8-K · Current report | Jun 15, 2026 | Current report | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| UPLOAD · Letter from the SEC | Apr 14, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 2, 2026 | Current report | SEC |
| CORRESP · Letter to the SEC | Mar 18, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 4, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 17, 2026 | Results | SEC |
| 10-Q · Quarterly report | Feb 17, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 11, 2026 | Current report | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2025 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Nov 12, 2025 | Current report | SEC |
| 8-K · Current report | Nov 12, 2025 | Current report | SEC |
| 8-K · Current report | Nov 10, 2025 | Current report | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 22, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 14, 2025 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2025 | Current report | SEC |
| 4 · Change in ownership | Jul 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 8, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 30, 2025 | Results | SEC |
| 10-K · Annual report | Jun 30, 2025 | Annual report | SEC |
| 8-K · Current report | Jun 23, 2025 | Current report | SEC |
| 8-K · Current report | Jun 16, 2025 | Current report | SEC |
| 8-K · Current report | Apr 30, 2025 | Current report | SEC |
| 8-K · Current report | Mar 3, 2025 | Current report | SEC |
| 8-K · Current report | Feb 13, 2025 | Results | SEC |
| 10-Q · Quarterly report | Feb 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Dec 26, 2024 | Current report | SEC |
| 8-K · Current report | Dec 2, 2024 | Current report | SEC |
| 8-K · Current report | Nov 18, 2024 | Current report | SEC |
| 8-K · Current report | Nov 14, 2024 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 28, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 23, 2024 | Other filings | SEC |
| 8-K · Current report | Oct 10, 2024 | Current report | SEC |
| 8-K · Current report | Oct 7, 2024 | Current report | SEC |
| 8-K · Current report | Aug 27, 2024 | Current report | SEC |
| 8-K · Current report | Aug 14, 2024 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | Jul 1, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 1, 2024 | Results | SEC |
| 10-K · Annual report | Jul 1, 2024 | Annual report | SEC |
| 8-K · Current report | Jun 21, 2024 | Material contract | SEC |
| 8-K · Current report | Jun 5, 2024 | Current report | SEC |
| 8-K · Current report | May 20, 2024 | Current report | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Apr 2, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 28, 2024 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Mar 28, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Feb 28, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 20, 2024 | Other filings | SEC |
| 8-K · Current report | Feb 14, 2024 | Results | SEC |
| 10-Q · Quarterly report | Feb 14, 2024 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | Jan 22, 2024 | Other filings | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 26, 2023 | Current report | SEC |
| 8-K · Current report | Dec 12, 2023 | Current report | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 14, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Sep 25, 2023 | Current report | SEC |
| 8-K · Current report | Sep 7, 2023 | Material contract | SEC |
| 8-K · Current report | Aug 14, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Jul 31, 2023 | Annual report | SEC |
| 8-K · Current report | Jul 17, 2023 | Current report | SEC |
| 8-K · Current report | Jun 29, 2023 | Results | SEC |
| 10-K · Annual report | Jun 29, 2023 | Annual report | SEC |
| 4 · Change in ownership | Jun 26, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 8, 2023 | Insider trade | SEC |
| 8-K · Current report | May 3, 2023 | Material contract | SEC |
| 8-K · Current report | Apr 20, 2023 | Current report | SEC |
| 8-K · Current report | Feb 28, 2023 | Management or board change | SEC |
| 8-K · Current report | Feb 14, 2023 | Results | SEC |
| 10-Q · Quarterly report | Feb 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Dec 22, 2022 | Current report | SEC |
| 8-K · Current report | Nov 28, 2022 | Material contract | SEC |
| 8-K · Current report | Nov 15, 2022 | Results | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 14, 2022 | Insider trade | SEC |
| 8-K · Current report | Nov 10, 2022 | Current report | SEC |
| 8-K · Current report | Nov 2, 2022 | Current report | SEC |
| 3 · Initial statement of ownership | Sep 13, 2022 | Insider trade | SEC |
| 8-K · Current report | Sep 7, 2022 | Material contract | SEC |
| 4 · Change in ownership | Aug 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 26, 2022 | Current report | SEC |
| 8-K · Current report | Aug 15, 2022 | Results | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 7, 2022 | Insider trade | SEC |
| 8-K · Current report | Jun 29, 2022 | Results | SEC |
| 10-K · Annual report | Jun 29, 2022 | Annual report | SEC |
| 8-K · Current report | Jun 29, 2022 | Current report | SEC |
| 3 · Initial statement of ownership | Jun 3, 2022 | Insider trade | SEC |
| 8-K · Current report | May 11, 2022 | Material contract | SEC |
| 8-K · Current report | Apr 18, 2022 | Management or board change | SEC |
| 8-K · Current report | Apr 4, 2022 | Current report | SEC |
| 8-K · Current report | Feb 14, 2022 | Results | SEC |
| 10-Q · Quarterly report | Feb 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Dec 9, 2021 | Material contract | SEC |
| 8-K · Current report | Dec 2, 2021 | Material contract | SEC |
| 8-K · Current report | Dec 2, 2021 | Material contract | SEC |
| 8-K · Current report | Nov 15, 2021 | Results | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Aug 16, 2021 | Results | SEC |
| 10-Q · Quarterly report | Aug 16, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 7, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2021 | Insider trade | SEC |
| 10-K/A · Annual report, amended | Jun 22, 2021 | Annual report | SEC |
| 8-K · Current report | Jun 14, 2021 | Results | SEC |
| 10-K · Annual report | Jun 14, 2021 | Annual report | SEC |
| 3 · Initial statement of ownership | May 19, 2021 | Insider trade | SEC |
| 8-K · Current report | May 5, 2021 | Current report | SEC |
| 8-K · Current report | Apr 29, 2021 | Material contract | SEC |
| 8-K · Current report | Apr 12, 2021 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Mar 12, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 22, 2021 | Other filings | SEC |
| 8-K · Current report | Feb 16, 2021 | Results | SEC |
| 10-Q · Quarterly report | Feb 16, 2021 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | Feb 9, 2021 | Other filings | SEC |
| 8-K · Current report | Nov 16, 2020 | Results | SEC |
| 10-Q · Quarterly report | Nov 16, 2020 | Quarterly report | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 1, 2020 | Big-stake notice | SEC |
| 8-K · Current report | Aug 27, 2020 | Financing | SEC |
| 4 · Change in ownership | Aug 26, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Aug 24, 2020 | Insider trade | SEC |
| 8-K · Current report | Aug 17, 2020 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2020 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Jul 31, 2020 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Jul 28, 2020 | Other filings | SEC |
| 424B3 · Prospectus | Jul 27, 2020 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jul 23, 2020 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 22, 2020 | Other filings | SEC |
| S-3 · Registration statement | Jul 15, 2020 | Offer document | SEC |
| D | Jul 13, 2020 | Other filings | SEC |
| 8-K · Current report | Jul 9, 2020 | Material contract | SEC |
| 4 · Change in ownership | Jul 6, 2020 | Insider trade | SEC |
| 8-K · Current report | Jun 29, 2020 | Results | SEC |
| 10-K · Annual report | Jun 29, 2020 | Annual report | SEC |
| 8-K · Current report | Jun 24, 2020 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | May 11, 2020 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 29, 2020 | Meeting notice | SEC |
| 8-K · Current report | Apr 22, 2020 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Apr 17, 2020 | Meeting notice | SEC |
| 8-K · Current report | Feb 26, 2020 | Material contract | SEC |
| 8-K · Current report | Feb 10, 2020 | Results | SEC |
| 10-Q · Quarterly report | Feb 10, 2020 | Quarterly report | SEC |
| 8-K · Current report | Dec 12, 2019 | Current report | SEC |
| 8-K · Current report | Dec 5, 2019 | Meeting outcome | SEC |
| 8-K · Current report | Nov 19, 2019 | Material contract | SEC |
| 8-K · Current report | Nov 12, 2019 | Results | SEC |
| 10-Q · Quarterly report | Nov 12, 2019 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Oct 18, 2019 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 10, 2019 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 27, 2019 | Meeting notice | SEC |
| 8-K · Current report | Sep 12, 2019 | Current report | SEC |
| 8-K · Current report | Aug 9, 2019 | Results | SEC |
| 10-Q · Quarterly report | Aug 9, 2019 | Quarterly report | SEC |
| 8-K · Current report | Jun 21, 2019 | Results | SEC |
| 10-K · Annual report | Jun 21, 2019 | Annual report | SEC |
| NT 10-K · Late filing notice | Jun 14, 2019 | Explanation request | SEC |
| 8-K · Current report | Mar 11, 2019 | Material contract | SEC |
| 8-K · Current report | Feb 11, 2019 | Results | SEC |
| 10-Q · Quarterly report | Feb 11, 2019 | Quarterly report | SEC |
| 8-K · Current report | Jan 3, 2019 | Current report | SEC |
| 8-K · Current report | Dec 10, 2018 | Current report | SEC |
| 8-K · Current report | Nov 20, 2018 | Current report | SEC |
| 8-K · Current report | Nov 9, 2018 | Results | SEC |
| 10-Q · Quarterly report | Nov 9, 2018 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2018 | Current report | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Elite Pharmaceuticals, Inc.’s releases · as of Nov 12, 2026
- Common shares
- 1,077,569,775
- Fully diluted
- 1,077,569,775
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 1,077,569,775 | Nov 12, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 12, 2026 | 1,077,569,775 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jerry Treppel Other companies: Akorn Inc (Director · Jan 13, 2006 – Aug 7, 2009 · Past) | Chairman of Board, Director · Oct 28, 2008 – Nov 13, 2015 · Past |
| Barry Dash | Director · Since at least Aug 28, 2022 |
| Carter Ward | Chief Financial Officer · Since at least Nov 5, 2026 |
| Charan Behl | Exec V.P. & Chief Sci Officer · Mar 9, 2006 – Nov 13, 2006 · Past |
| Chris Dick | President & COO, Director · Mar 9, 2006 – Mar 7, 2013 · Past |
| Chris Dick | Head of Development · Since at least Nov 4, 2026 |
| Davis S. Caskey | Director · Since at least Feb 26, 2018 |
| Dianne Will | Investor Relations · Since at least Nov 3, 2026 |
| Douglas Plassche | EVP Operations · Since at least Mar 31, 2015 |
| Doug Plassche | Executive Vice President of Operations · Since at least Nov 4, 2026 |
All 17 people
| Person | Seat |
|---|---|
| G. Kenneth Smith | Vice President of Legal · Since at least Nov 5, 2026 |
| Jeffrey Whitnell | Director · Since at least Nov 5, 2026 |
| Kirko Kirkov | Chief Commercial Officer · Since at least Sep 6, 2022 |
| Marc Bregman | CFO, Secretary, Treasurer · May 17, 2021 – May 17, 2021 · Past |
| Mark N Pellegrino | CFO, Secretary, Treasurer · May 1, 2023 – May 1, 2023 · Past |
| Nasrat Hakim | Chairman, President & Chief Executive Officer · Since at least Nov 3, 2026 |
| Robert C J Chen | CFO, Secretary, Treasurer · May 16, 2022 – May 16, 2022 · Past |
Log in to ask 6ix AI your own questions about Elite Pharmaceuticals, Inc.